ALGN — Align Technology, Inc. stock price, charts and financials

QT56Align Technology, Inc.

Align Technology, Inc. (NASDAQ: ALGN) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
175.65
+1.98+1.14%
ALGNQT56Align Technology, Inc.·NASDAQ
175.65+1.14%
TA
Loading chart...
Screen all →
Snapshot
IndexS&P 500P/E30.15EPS (ttm)5.76Insider Own1.02%Shs Outstand71.62MPerf Week2.66%
Market Cap12.44BForward P/E13.87EPS next Y12.52Insider Trans-1.09%Shs Float66.91MPerf Month-2.53%
Enterprise Value12.44BPEG-EPS next Q2.81Inst Own-Short Float7.21%Perf Quarter3.13%
Income414.16MP/S3.00EPS this Y95.83%Inst Trans-Short Ratio4.63Perf Half Y-1.12%
Sales4.14BP/B-EPS next Y11.00%ROA6444.45%Short Interest4.83MPerf YTD11.21%
Book/sh-P/C16.42EPS next 5Y10.80%ROE13.60%52W High202.73 -13.36%Perf Year26.85%
Cash/sh-P/FCF16.46EPS past 3/5Y7.02% -24.09%ROIC8830.41%52W Low123.40 42.34%Perf 3Y-52.73%
Dividend Est.-EV/EBITDA15.82Sales past 3/5Y2.61% 10.30%Gross Margin66.48%Volatility3.18% 3.77%Perf 5Y-75.04%
Dividend TTM-EV/Sales3.00EPS Y/Y TTM2.49%Oper. Margin13.33%ATR (14)7.31Perf 10Y103.64%
Dividend Ex-Date-Quick Ratio1.28Sales Y/Y TTM3.53%Profit Margin9.99%RSI (14)49.57Recom2.33
Dividend Gr. 3/5Y-Current Ratio1.40EPS Q/Q6.02%SMA20-0.36%Beta1.61Target Price203.50
Payout0.00%Debt/Eq0.03Sales Q/Q4.35%SMA50-0.59%Rel Volume0.84Prev Close173.66
Employees20,290LT Debt/Eq0.02EarningsOct 28SMA2003.52%Avg Volume1.03MPrice175.65
IPO DateJan 30, 2001Option/ShortYes / YesEPS/Sales Surpr.0.91% 0.40%Net Debt/EBITDA-0.00Volume869,858Change1.14%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-23-26ReiteratedUBSNeutral$186$189
Jul-08-26InitiatedBMO CapitalOutperform$209
Apr-24-26ReiteratedMorgan StanleyEqual Weight$154$188
Apr-21-26ReiteratedPiper SandlerOverweight$220$235
Mar-17-26UpgradeBarclaysEqual WeightOverweight
Feb-09-26UpgradeHSBCHoldBuy$200
Feb-05-26ReiteratedStifel NicolausBuy$200$210
Feb-05-26ReiteratedRobert W. Baird$205$218
Feb-05-26ReiteratedPiper SandlerOverweight$200$220
Feb-05-26ReiteratedWells FargoOverweight$200
Latest News
Aug-07-26
Aug-06-26
Aug-04-26
Aug-03-26
Jul-31-26
Jul-30-26
Jul-29-26
Company

Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue4,1404,0353,999
Cost of Goods Sold Incl. D&A1,3871,2781,200
Gross Profit2,7522,7572,799
Selling, General and Administrative Excl. Other1,7871,7561,763
Research and Development377370364
Other Operating Expense371565
Operating Income552616608
Interest Expense
200
Unusual Expense
Non-Operating Income (Expense)18-311
Net Income Before Taxes570585609
Income Taxes155175188
Consolidated Net Income414410421
Net Income From Continuing Operations414410421
Net Income414410421
EPS (Recurring)5.765.665.63
EPS (Basic, Before Extraordinaries)5.765.665.63
EPS (Diluted)5.765.655.62
EBITDA787766817
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio30.4927.6437.10
Price To Sales Ratio3.012.833.91
Gross Margin66.4768.3369.99
Operating Margin13.3315.2715.20
Net Margin10.0010.1610.53
Shares Outstanding717375
Market Capitalization12,47111,39915,638
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$219.54$192.79$166.03$139.28$112.53 Close Price0.00M0.38M0.75M1.13M1.51MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Conroy Kevin TDirectorMay 20 '26Option Exercise0.001,74503,553May 22
MORROW GEORGE JDirectorMay 20 '26Option Exercise0.001,74505,036May 22
Vitalone Britt J.DirectorMay 20 '26Option Exercise0.001,44301,443May 22
Saia Andrea LynnDirectorMay 20 '26Option Exercise0.001,745017,318May 22
Poul MojdehDirectorMay 20 '26Option Exercise0.001,74503,553May 22
Myong AnneDirectorMay 20 '26Option Exercise0.001,74509,830May 22
SIEGEL SUSAN EDirectorMay 20 '26Option Exercise0.001,745010,723May 22
LARKIN C RAYMOND JRDirectorMay 20 '26Option Exercise0.002,326027,454May 22
Dallas Kevin JDirectorMay 20 '26Option Exercise0.001,745016,168May 22
LACOB JOSEPHDirectorMay 20 '26Option Exercise0.001,7450135,916May 22
Coletti Julie AnnEVP, CHIEF LEGAL & REGULATORYFeb 20 '26Option Exercise0.0011,728013,163Feb 24
HOGAN JOSEPH MPresident and CEOFeb 20 '26Option Exercise0.0080,4963225,377Feb 24
Morici JohnEVP, CHIEF FINANCIAL OFFICERFeb 20 '26Option Exercise0.0015,696016,085Feb 24
Hockridge Stuart AEVP, GLOBAL HRFeb 20 '26Option Exercise0.008,620016,102Feb 24
Morici JohnEVP, CHIEF FINANCIAL OFFICERFeb 18 '26Sale189.317,9691,508,6468,237Feb 20
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.